Biological Material Transfer Agreement Template for South Africa
Generate a bespoke document
What is a Biological Material Transfer Agreement?
The Biological Material Transfer Agreement (MTA) is a crucial legal instrument used in South Africa when biological materials need to be transferred between organizations for research, development, or other authorized purposes. This document is essential for compliance with South African legislation, particularly NEMBA and BABS regulations, which govern biodiversity management and benefit-sharing. The agreement is commonly used by research institutions, universities, biotechnology companies, and other organizations involved in life sciences. It includes specific provisions for material handling, permitted uses, intellectual property rights, and where applicable, benefit-sharing arrangements with indigenous knowledge holders. The MTA ensures proper documentation of material transfer, protects both provider and recipient interests, and maintains compliance with national and international regulations regarding biological resource use.
Trusted by high-performance teams
About the Biological Material Transfer Agreement
When you need to transfer biological materials for research or development purposes in South Africa, a Biological Material Transfer Agreement (MTA) serves as your essential legal safeguard. This document ensures that your material transfers comply with South African biodiversity laws while protecting the interests of both the providing and receiving organizations. Whether you're working with plant specimens, microbial cultures, genetic materials, or other biological resources, this agreement establishes the legal framework for responsible sharing and use.
When do you need this document?
You'll require an MTA whenever biological materials cross organizational boundaries for research purposes. This includes transfers between universities and pharmaceutical companies for drug discovery, sharing of indigenous plant materials with biotechnology firms for product development, or exchanging microbial cultures between research institutions. The agreement is particularly crucial when your research involves commercially valuable biological resources or when working with materials that may be subject to benefit-sharing requirements under South African law. International collaborations involving South African biological materials also mandate proper MTA documentation to ensure regulatory compliance.
Key legal considerations
Your MTA must clearly define the scope of permitted uses, whether for basic research, product development, or commercial applications. Intellectual property clauses require careful attention, particularly regarding ownership of discoveries or innovations derived from the transferred materials. If your research involves indigenous biological resources, you must address benefit-sharing obligations and ensure proper consultation with affected communities. The agreement should specify handling and storage requirements, publication rights, and restrictions on further distribution to third parties. Consider including termination clauses that allow either party to end the agreement under specific circumstances, and ensure that liability and indemnification provisions adequately protect both organizations.
Legal requirements in South Africa
Under the National Environmental Management: Biodiversity Act (NEMBA) and BABS regulations, your MTA must comply with South Africa's biodiversity management framework. If your transfer involves bioprospecting activities, you'll need to obtain proper permits and demonstrate compliance with benefit-sharing requirements. The agreement must align with the Department of Science and Technology's MTA guidelines, which provide specific frameworks for biological material transfers. When dealing with indigenous biological resources, you must ensure that traditional knowledge holders receive fair and equitable benefit-sharing as mandated by BABS regulations. Your MTA should also address potential patent implications under the Patents Act, particularly if the transferred materials may lead to commercial innovations or pharmaceutical developments.
GOVERNING LAW
Applicable law
This Biological Material Transfer Agreement is drafted to comply with South Africa law. Key legislation includes:
Bioprospecting, Access and Benefit-Sharing (BABS) Regulations of 2008: Specific regulations under NEMBA that govern the process of bioprospecting and the sharing of benefits arising from the use of indigenous biological resources
Patents Act No. 57 of 1978: Governs intellectual property rights related to biological materials and innovations derived from them
Material Transfer Agreement Guidelines (Department of Science and Technology): Provides framework and guidelines for the transfer of biological materials for research purposes in South Africa
National Health Act No. 61 of 2003: Relevant for transfer of human biological materials and associated research ethics requirements
Genetically Modified Organisms Act No. 15 of 1997: Important if the biological materials involve GMOs or could be used to create GMOs
Convention on Biological Diversity (CBD): International agreement to which South Africa is a party, providing framework for sustainable use of biological resources and fair benefit-sharing
Nagoya Protocol: International protocol on access to genetic resources and fair and equitable sharing of benefits arising from their utilization
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it

